290 related articles for article (PubMed ID: 22058034)
1. Mechanism and methods to induce pluripotency.
Wang P; Na J
Protein Cell; 2011 Oct; 2(10):792-9. PubMed ID: 22058034
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
Walia B; Satija N; Tripathi RP; Gangenahalli GU
Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
[TBL] [Abstract][Full Text] [Related]
4. Current methods for inducing pluripotency in somatic cells.
Tavernier G; Mlody B; Demeester J; Adjaye J; De Smedt SC
Adv Mater; 2013 May; 25(20):2765-71. PubMed ID: 23529911
[TBL] [Abstract][Full Text] [Related]
5. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
6. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
7. Importance of Myc-related microRNAs in induced pluripotency.
Çağlayan ES; Güran Ş
Cell Biol Int; 2015 Sep; 39(9):987-94. PubMed ID: 25809132
[TBL] [Abstract][Full Text] [Related]
8. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
9. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
11. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
12. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
Cong X; Zhang SM; Ellis MW; Luo J
Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.
Cerneckis J; Cai H; Shi Y
Signal Transduct Target Ther; 2024 Apr; 9(1):112. PubMed ID: 38670977
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.
Han JW; Yoon YS
Antioxid Redox Signal; 2011 Oct; 15(7):1799-820. PubMed ID: 21194386
[TBL] [Abstract][Full Text] [Related]
15. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.
Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M
Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336
[No Abstract] [Full Text] [Related]
16. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
[TBL] [Abstract][Full Text] [Related]
17. Present and future challenges of induced pluripotent stem cells.
Ohnuki M; Takahashi K
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
[TBL] [Abstract][Full Text] [Related]
18. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
[TBL] [Abstract][Full Text] [Related]
19. Development course and an application strategy for induced pluripotent stem cells in regenerative medicine.
Xu Y; Wang J; Mao R; Tang X; Huang R; Wang R; Lin Y
Curr Stem Cell Res Ther; 2014 May; 9(3):244-53. PubMed ID: 24524789
[TBL] [Abstract][Full Text] [Related]
20. Assessing iPSC reprogramming methods for their suitability in translational medicine.
Rao MS; Malik N
J Cell Biochem; 2012 Oct; 113(10):3061-8. PubMed ID: 22573568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]